Improving the safety of gene therapies 2 different ways Two groups of researchers have developed unique approaches to overcome the limitations of delivery of gene editing therapeutics. In a pair of new papers, researchers describe methods for more efficient and safe delivery of CRISPR components to targeted cells and tissues. Discuss
UCB expands gene therapy capabilities UCB has acquired Belgium-based Handl Therapeutics and formed a new collaboration with Florida-based Lacerta Therapeutics to accelerate the company's gene therapy activities.
WuXi increases GMP plasmid DNA services WuXi Advanced Therapies has expanded its cell and gene therapy platforms with capabilities to provide high-quality and cost-effective good manufacturing practice (GMP) plasmids.
Pluristyx supports Kiadis' COVID-19 NK cell therapy Pluristyx will be supporting Kiadis Pharma and the Advanced Regenerative Manufacturing Institute's BioFabUSA program by providing services for the research and development of Kiadis' natural killer (NK) cell COVID-19 therapy.
Digital microfluidic technique connects cells to their environment A new digital microfluidic technique allows researchers to connect physical cell properties with the molecular makeup of individual cells. This new approach, published in Nature Communications on November 11, will enable a deeper study of stem cells and other rare cell types for therapeutic development. Discuss